CSI Market
Sign In | Register

Sanara Medtech Inc (SMTI) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access SMTI quarterly Cash Flow →
Reviewing cash flow figures over time highlights how Sanara Medtech Inc balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-37.57
Depreciation & amortization3.95
Amortization of Other Assets0.00
Accretion Expense0.00
Asset Impairment Charges28.31
Provision For Loan Losses Expensed0.51
Inventories Decrease /-Increase-1.20
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property-0.01
Share-based Compensation5.15
Income (Loss) from Equity Method Investments0.95
Paid-in-Kind Interest2.20
Re Acquisition Of Distributorship-
Gain On Fair Market Value Of Derivative Liabilities-
Gain Loss On Debt Settlement-
Loss On Debt Settlement-
Prepayment Expense-
Impairment Of Intangible Assets Excluding Goodwill-
Non Cash Debt Related Costs-
Stock Issued As Payment Of Expenses-
Stock Issued For Debt Related Costs-
Gain Loss On Joint Venture-
Derivative Gain Loss On Derivative Net-
Increase Decrease In Interest Receivable From Related Parties Current-
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest-
Common Stock Issued For Loan Extensions-
Gain Loss On Fair Market Value Of Derivative Liabilities-
Series D Preferred Shares Issued For Services-
Stock Issued During Period Value Issued For Services-
Embedded Derivative Gain Loss On Embedded Derivative Net-
Interest Expense On Convertible Debt-
Increase Decrease In Prepaid Deferred Expense And Other Assets Related Parties-
Debt Instrument Increase Accrued Interest-
Income taxes0.00
Equity Method Investment, Realized Gain (Loss) on Disposal0.00
Increase (Decrease) in Accounts Receivable-0.07
Increase (Decrease) in Accounts Payable0.81
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.12
Other Working Capital0.00
Other Noncash Expense0.53
Other net0.00
Payments for (Proceeds from) Other Operating Activities3.10
Discontinued operations0.00
Net Cash flow from Operating Activities6.79
Investing Activities
Capital Expenditures-4.65
Sale of Capital Items0.06
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Cash Received In Reverse Acquisition-
Restricted Cash and Investments Increase (Decrease)0.00
Payments to Acquire Loans Receivable0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Payments to Acquire Equity Method Investments-8.26
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-2.12
Discontinued operations0.00
Net Cash Flow from Investing Activities-14.97
Financing Activities
Short-term debt Net12.02
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-1.65
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Payments of Distributions to Affiliates0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-1.48
Proceeds From Notes Payable Related Parties-
Repayments Of Notes Payable Related Parties-
Proceeds From Stock Subscriptions Payable-
Proceeds From Stock Subscriptions Receivable-
Borrowings On Debt-
Borrowings On Convertible Debt Net Of Original Issue Discounts-
Payments On Convertible Debt-
Advance On Future Non Controlling Interest Distribution-
Common Stock Issued For Employee Stock Purchase Plan-
Interest Expense Debt-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities8.89
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow2.20
Total Cash Flow0.70
4 historic quarters locked

Sign in to unlock the full Sanara Medtech Inc cash flow history.

Sign In Create Free Account

About Sanara Medtech Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 24, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-012352

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License